Related Experiment Video

Updated: Apr 27, 2026

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy
07:52

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

20.5K

The complexity of the cardio-renal link: taxonomy, syndromes, and diseases

Carmine Zoccali1, David Goldsmith2, Rajiv Agarwal3

  • 1Nephrology, Dialysis and Transplantation Unit and CNR-IBIM Clinical Epidemiology and Pathophysiology of Renal Diseases and Hypertension , Reggio Calabria, Italy.

Kidney International Supplements
|July 17, 2014
PubMed

Insights

The complex relationship between heart and kidney diseases requires a new medical discipline, cardiovascular and renal medicine. Understanding these links is crucial for improving patient outcomes and developing targeted treatments.

Area of Science:

  • Cardiovascular Medicine
  • Nephrology
  • Translational Science

Background:

  • Bidirectional links between cardiovascular (CV) and renal diseases are complex and poorly understood.
  • Existing treatments like dialysis have limited success in reducing mortality in end-stage renal disease patients with CV complications.
  • There is a need to define new syndromes and therapeutic approaches at the intersection of cardiology and nephrology.

Approach:

  • Focus on the interconnectedness of the arterial system, heart, kidney, and other bodily systems.
  • Investigate the efficacy of interventions such as extracorporeal ultrafiltration in decompensated heart failure.
  • Integrate basic science, clinical research, epidemiology, and medical technology to advance the field.

Key Points:

  • The arterial system, heart, and kidney share multiple connections with metabolic and musculoskeletal systems.
  • Dialysis offers limited success in preventing cardiovascular and non-cardiovascular death in end-stage renal disease.
  • The benefits and timing of extracorporeal ultrafiltration for heart failure require further investigation.

Conclusions:

  • The emerging discipline of 'cardiovascular and renal medicine' is essential for addressing the shared challenges in treating heart and kidney diseases.
  • Further research is needed to delineate new syndromes and optimize patient care.
  • Collaboration between cardiologists, nephrologists, and intensivists is vital for advancing this field.

Keywords:
CKDESRDcardio-renalcardiovascular riskdeathprogression of CKD

More Related Videos

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches06:51

Multilevel Microdissection and Functional-Structural Profiling of Human Renal Arterial Branches

Published on: September 5, 2025

777
Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury10:25

Normothermic Cardiac Arrest and Cardiopulmonary Resuscitation: A Mouse Model of Ischemia-Reperfusion Injury

Published on: August 30, 2011

17.3K

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
813
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.7K
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
936
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.7K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K